Press Releases
Washington, D.C. (August 16, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the decision by the United States U.S. Fifth Circuit Court of Appeals to restrict access to the U.S. Food and Drug Administration's (FDA) approved abortion medication:
Washington, D.C. (August 16, 2023)—Today, Rep.
Washington, D.C. (August 14, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, released a statement following Committee Republicans' release of the full transcript from an interview the Committee conducted four weeks ago with a former FBI supervisory agent assigned to the Hunter Biden investigation:
| Washington, D.C. (August 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Attorney General Merrick Garland announced U.S. Attorney David Weiss's appointment as special counsel: |
Washington, D.C. (August 3, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, released a memo showing how Committee Republicans have grossly misrepresented the transcribed interview the Committee conducted with Devon Archer, Hunter Biden's former business associate.
Washington, D.C. (July 31, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after the Committee concluded a transcribed interview with Devon Archer:
Washington, D.C. (July 28, 2023)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, led Democrats in urging bipartisan support for the reauthorization of the Office of National Drug Control Policy (ONDCP), an agency critical in the Biden-Harris Administration's efforts to fight the drug addiction epidemic and curb overdose deaths.
Washington, D.C. (July 28, 2023)—Rep.
Washington, D.C. (July 28, 2023)—Yesterday, Rep. Raul Ruiz, M.D., Ranking Member of the Select Subcommittee on the Coronavirus Pandemic, led Select Subcommittee Democrats in prioritizing the health and safety of the American people by underscoring the safety and effectiveness of COVID-19 vaccines, highlighting the success of policies that increased their uptake, and pushing back against misinformation that undermines vaccine confidence.